{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:15:15Z","timestamp":1788416115605,"version":"build-2803163510"},"reference-count":63,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["55006749"],"award-info":[{"award-number":["55006749"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI115993"],"award-info":[{"award-number":["R21AI115993"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UO1HD085531-02"],"award-info":[{"award-number":["UO1HD085531-02"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1158806"],"award-info":[{"award-number":["OPP1158806"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009467","name":"University of the Witwatersrand, Johannesburg","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100009467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["260872"],"award-info":[{"award-number":["260872"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001342","name":"Department of Science and Technology, Republic of South Africa","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,20]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>Tuberculosis (TB) is the leading cause of mortality globally resulting from an infectious disease, killing almost 1.6 million people annually and accounting for approximately 30% of deaths attributed to antimicrobial resistance (AMR). This despite the widespread administration of a neonatal vaccine, and the availability of an effective combination drug therapy against the causative agent, Mycobacterium tuberculosis (Mtb). Instead, TB prevalence worldwide is characterized by high-burden regions in which co-epidemics, such as HIV, and social and economic factors, undermine efforts to control TB. These elements additionally ensure conditions that favor the emergence of drug-resistant Mtb strains, which further threaten prospects for future TB control.<\/jats:p>\n                  <jats:p>To address this challenge, significant resources have been invested in developing a TB drug pipeline, an initiative given impetus by the recent regulatory approval of two new anti-TB drugs. However, both drugs have been reserved for drug-resistant disease, and the seeming inevitability of new resistance plus the recognized need to shorten the duration of chemotherapy demands continual replenishment of the pipeline with high-quality \u201chits\u201d with novel mechanisms of action. This represents a massive challenge, which has been undermined by key gaps in our understanding of Mtb physiology and metabolism, especially during host infection. Whereas drug discovery for other bacterial infections can rely on predictive in vitro assays and animal models, for Mtb, inherent metabolic flexibility and uncertainties about the nutrients available to infecting bacilli in different host (micro)environments instead requires educated predictions or demonstrations of efficacy in animal models of arguable relevance to human disease. Even microbiological methods for enumeration of viable mycobacterial cells are fraught with complication.<\/jats:p>\n                  <jats:p>Our research has focused on elucidating those aspects of mycobacterial metabolism that contribute to the robustness of the bacillus to host immunological defenses and applied antibiotics and that, possibly, drive the emergence of drug resistance. This work has identified a handful of metabolic pathways that appear vulnerable to antibiotic targeting. Those highlighted, here, include the inter-related functions of pantothenate and coenzyme A biosynthesis and recycling and nucleotide metabolism\u2500the last of which reinforces our view that DNA metabolism constitutes an under-explored area for new TB drug development. Although nonessential functions have traditionally been deprioritized for antibiotic development, a common theme emerging from this work is that these very functions might represent attractive targets because of the potential to cripple mechanisms critical to bacillary survival under stress (for example, the RelMtb-dependent stringent response) or to adaptability under unfavorable, potentially lethal, conditions including antibiotic therapy (for example, DnaE2-dependent SOS mutagenesis). The bar, however, is high: demonstrating convincingly the likely efficacy of this strategy will require innovative models of human TB disease.<\/jats:p>\n                  <jats:p>In the concluding section, we focus on the need for improved techniques to elucidate mycobacterial metabolism during infection and its impact on disease outcomes. Here, we argue that developments in other fields suggest the potential to break through this barrier by harnessing chemical-biology approaches in tandem with the most advanced technologies. As researchers based in a high-burden country, we are impelled to continue participating in this important endeavor.<\/jats:p>","DOI":"10.1021\/acs.accounts.9b00275","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T10:19:55Z","timestamp":1564481995000},"page":"2340-2348","source":"Crossref","is-referenced-by-count":18,"title":["Harnessing Biological Insight to Accelerate Tuberculosis\nDrug Discovery"],"prefix":"10.1021","volume":"52","author":[{"given":"Timothy J.","family":"de Wet","sequence":"first","affiliation":[{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]},{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digby F.","family":"Warner","sequence":"additional","affiliation":[{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]},{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4824-9115","authenticated-orcid":true,"given":"Valerie","family":"Mizrahi","sequence":"additional","affiliation":[{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]},{"name":"University of Cape Town , , Observatory, ,","place":["Cape Town, South Africa, 7925"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"2026090301340066000_cit1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","article-title":"Ecology and\nevolution of Mycobacterium tuberculosis","volume":"16","author":"Gagneux","year":"2018","journal-title":"Nat.\nRev. Microbiol."},{"key":"2026090301340066000_cit2","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.1038\/nrdp.2016.77","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nature Reviews Disease Primers"},{"key":"2026090301340066000_cit3","unstructured":"World Health Organization.\n          .  Global Tuberculosis Report, 2018."},{"key":"2026090301340066000_cit4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(19)30024-8","article-title":"Building\na tuberculosis-free world: The Lancet Commission on tuberculosis","volume":"393","author":"Reid","year":"2019","journal-title":"Lancet"},{"key":"2026090301340066000_cit5","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.ijid.2019.02.006","article-title":"The changing\ntreatment\nlandscape for MDR\/XDR-TB - Can current clinical trials revolutionise\nand inform a brave new world?","volume":"80S","author":"Honeyborne","year":"2019","journal-title":"Int. J. Infect.\nDis."},{"key":"2026090301340066000_cit6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mib.2018.02.006","article-title":"Priming the tuberculosis drug pipeline: new antimycobacterial\ntargets and agents","volume":"45","author":"Evans","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"2026090301340066000_cit7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for Multidrug-Resistant Pulmonary Tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2026090301340066000_cit8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A Diarylquinoline Drug Active on\nthe ATP Synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"2026090301340066000_cit9","unstructured":"World Health Organization.\n          .  Treatment Guidelines for Multidrug- and\nRifampicin-Resistant Tuberculosis, 2018."},{"key":"2026090301340066000_cit10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the\nbiology of Mycobacterium tuberculosis from the complete\ngenome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"2026090301340066000_cit11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/iub.1866","article-title":"Drug permeation\nand metabolism in Mycobacterium tuberculosis: Prioritising\nlocal exposure as essential criterion in new TB drug development","volume":"70","author":"Tanner","year":"2018","journal-title":"IUBMB Life"},{"key":"2026090301340066000_cit12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1128\/CMR.00060-05","article-title":"Tuberculosis chemotherapy: the influence of bacillary\nstress and damage response pathways on drug efficacy","volume":"19","author":"Warner","year":"2006","journal-title":"Clin Microbiol Rev."},{"key":"2026090301340066000_cit13","doi-asserted-by":"publisher","first-page":"a021121","DOI":"10.1101\/cshperspect.a021121","article-title":"Mycobacterium tuberculosis metabolism","volume":"5","author":"Warner","year":"2015","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"2026090301340066000_cit14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0378-1119(99)00114-6","article-title":"Cloning and\ncharacterization of a bifunctional RelA\/SpoT homologue from Mycobacterium tuberculosis","volume":"233","author":"Avarbock","year":"1999","journal-title":"Gene"},{"key":"2026090301340066000_cit15","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1128\/JB.182.17.4889-4898.2000","article-title":"The stringent response of Mycobacterium tuberculosis is required for long-term survival","volume":"182","author":"Primm","year":"2000","journal-title":"J. Bacteriol."},{"key":"2026090301340066000_cit16","doi-asserted-by":"publisher","first-page":"10026","DOI":"10.1073\/pnas.1631248100","article-title":"The role of RelMtb-mediated adaptation\nto stationary phase in long-term persistence of Mycobacterium tuberculosis in mice","volume":"100","author":"Dahl","year":"2003","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"key":"2026090301340066000_cit17","doi-asserted-by":"publisher","first-page":"eaav2104","DOI":"10.1126\/sciadv.aav2104","article-title":"Inhibiting the stringent response\nblocks Mycobacterium tuberculosis entry into quiescence\nand reduces persistence","volume":"5","author":"Dutta","year":"2019","journal-title":"Sci. Adv."},{"key":"2026090301340066000_cit18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1574-695X.2009.00606.x","article-title":"Resuscitation-promoting\nfactors as lytic enzymes for\nbacterial growth and signaling","volume":"58","author":"Kana","year":"2010","journal-title":"FEMS Immunol.\nMed. Microbiol."},{"key":"2026090301340066000_cit19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors\nof Mycobacterium tuberculosis are required for virulence\nand resuscitation from dormancy but are collectively dispensable for\ngrowth in vitro","volume":"67","author":"Kana","year":"2008","journal-title":"Mol. Microbiol."},{"key":"2026090301340066000_cit20","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1164\/rccm.201604-0769OC","article-title":"Detection and Quantification\nof Differentially\nCulturable Tubercle Bacteria in Sputum from Patients with Tuberculosis","volume":"194","author":"Chengalroyen","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026090301340066000_cit21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1164\/rccm.201607-1431ED","article-title":"New Evidence for the\nComplexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges","volume":"194","author":"Dartois","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026090301340066000_cit22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/82_2013_328","article-title":"DNA metabolism\nin mycobacterial pathogenesis","volume":"374","author":"Warner","year":"2013","journal-title":"Curr. Top. Microbiol.\nImmunol."},{"key":"2026090301340066000_cit23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1046\/j.1365-2958.1998.01038.x","article-title":"DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence?","volume":"29","author":"Mizrahi","year":"1998","journal-title":"Mol. Microbiol."},{"key":"2026090301340066000_cit24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-3-319-64371-7_13","article-title":"DNA Replication Fidelity\nin the Mycobacterium tuberculosis Complex","volume":"1019","author":"Warner","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"2026090301340066000_cit25","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0027-2016","article-title":"DNA Replication\nin Mycobacterium tuberculosis","author":"Ditse","year":"2017","journal-title":"Microbiol. Spectrum"},{"key":"2026090301340066000_cit26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0092-8674(03)00270-8","article-title":"DnaE2 polymerase\ncontributes to in vivo survival and the emergence of drug resistance\nin Mycobacterium tuberculosis","volume":"113","author":"Boshoff","year":"2003","journal-title":"Cell"},{"key":"2026090301340066000_cit27","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/JB.01135-09","article-title":"Role of the DinB homologs\nRv1537 and Rv3056 in Mycobacterium tuberculosis","volume":"192","author":"Kana","year":"2010","journal-title":"J. Bacteriol."},{"key":"2026090301340066000_cit28","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.1073\/pnas.1002614107","article-title":"Essential roles for imuA\u2019-\nand imuB-encoded accessory factors in DnaE2-dependent mutagenesis\nin Mycobacterium tuberculosis","volume":"107","author":"Warner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090301340066000_cit29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ng.3269","article-title":"DNA replication\nfidelity in Mycobacterium tuberculosis is mediated\nby an ancestral prokaryotic proofreader","volume":"47","author":"Rock","year":"2015","journal-title":"Nat.\nGenet."},{"key":"2026090301340066000_cit30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.chembiol.2015.08.015","article-title":"Elucidation\nof DnaE as the Antibacterial Target of the Natural Product","volume":"22","author":"Painter","year":"2015","journal-title":"Chem. Biol."},{"key":"2026090301340066000_cit31","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.aaa4690","article-title":"Antibiotics. Targeting DnaN for tuberculosis\ntherapy\nusing novel griselimycins","volume":"348","author":"Kling","year":"2015","journal-title":"Science"},{"key":"2026090301340066000_cit32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fmolb.2017.00075","article-title":"Targeting\nDNA Replication and Repair\nfor the Development of Novel Therapeutics against Tuberculosis","volume":"4","author":"Reiche","year":"2017","journal-title":"Front Mol. Biosci"},{"key":"2026090301340066000_cit33","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1038\/ncomms14246","article-title":"A non-canonical mismatch repair pathway in prokaryotes","volume":"8","author":"Castaneda-Garcia","year":"2017","journal-title":"Nat. Commun."},{"key":"2026090301340066000_cit34","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MGM2-0001-2013","article-title":"Nucleotide\nMetabolism and DNA Replication","author":"Warner","year":"2014","journal-title":"Microbiol. Spectrum"},{"key":"2026090301340066000_cit35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcimb.2014.00052","article-title":"Ribonucleotide\nreductases: essential enzymes for bacterial life","volume":"4","author":"Torrents","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2026090301340066000_cit36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1128\/JB.01409-08","article-title":"Function and\nregulation of class I ribonucleotide reductase-encoding genes in mycobacteria","volume":"191","author":"Mowa","year":"2009","journal-title":"J. Bacteriol."},{"key":"2026090301340066000_cit37","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1128\/IAI.71.11.6124-6131.2003","article-title":"Ribonucleotide reduction\nin Mycobacterium tuberculosis: function and expression\nof genes encoding class Ib and class II ribonucleotide reductases","volume":"71","author":"Dawes","year":"2003","journal-title":"Infect. Immun."},{"key":"2026090301340066000_cit38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.chembiol.2014.11.006","article-title":"The complex\nmechanism\nof antimycobacterial action of 5-fluorouracil","volume":"22","author":"Singh","year":"2015","journal-title":"Chem. Biol."},{"key":"2026090301340066000_cit39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00775-014-1121-x","article-title":"The class Ib ribonucleotide reductase from Mycobacterium tuberculosis has two active R2F subunits","volume":"19","author":"Hammerstad","year":"2014","journal-title":"JBIC, J. Biol. Inorg. Chem."},{"key":"2026090301340066000_cit40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1046\/j.1365-2958.2003.03474.x","article-title":"Rv3133c\/dosR is\na transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis","volume":"48","author":"Park","year":"2003","journal-title":"Mol. Microbiol."},{"key":"2026090301340066000_cit41","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2217\/fmb.13.113","article-title":"Vitamin B(12) metabolism\nin Mycobacterium tuberculosis","volume":"8","author":"Gopinath","year":"2013","journal-title":"Future Microbiol."},{"key":"2026090301340066000_cit42","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1128\/IAI.02722-14","article-title":"bis-Molybdopterin\nguanine dinucleotide is required for persistence of Mycobacterium\ntuberculosis in guinea pigs","volume":"83","author":"Williams","year":"2015","journal-title":"Infect. Immun."},{"key":"2026090301340066000_cit43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/acsinfecdis.6b00102","article-title":"The Inosine Monophosphate\nDehydrogenase, GuaB2, Is\na Vulnerable New Bactericidal Drug Target for Tuberculosis","volume":"3","author":"Singh","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"2026090301340066000_cit44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/acsinfecdis.6b00103","article-title":"Essential but Not Vulnerable: Indazole\nSulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential\nLeads against Mycobacterium tuberculosis","volume":"3","author":"Park","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"2026090301340066000_cit45","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00938-18","article-title":"Rational\nDesign of Biosafety Level 2-Approved, Multidrug-Resistant Strains\nof Mycobacterium tuberculosis through Nutrient Auxotrophy","author":"Vilcheze","year":"2018","journal-title":"mBio"},{"key":"2026090301340066000_cit46","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.chembiol.2012.05.020","article-title":"Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening","volume":"19","author":"Abrahams","year":"2012","journal-title":"Chem. Biol."},{"key":"2026090301340066000_cit47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acsinfecdis.6b00150","article-title":"Validation of CoaBC\nas a Bactericidal\nTarget in the Coenzyme A Pathway of Mycobacterium tuberculosis","volume":"2","author":"Evans","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"2026090301340066000_cit48","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.61","article-title":"Aspartate\ndecarboxylase\n(PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis","volume":"3","author":"Shi","year":"2014","journal-title":"Emerging Microbes Infect."},{"key":"2026090301340066000_cit49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/acsinfecdis.7b00079","article-title":"Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by\nBinding to Aspartate Decarboxylase PanD","volume":"3","author":"Gopal","year":"2017","journal-title":"ACS\nInfect. Dis."},{"key":"2026090301340066000_cit50","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/jac\/dky060","article-title":"\u2019Happy the man, who, studying\nnature\u2019s laws, Thro\u2019 known effects can trace the secret\ncause.\u2019 Do we have enough pieces to solve the pyrazinamide\npuzzle?","volume":"73","author":"Anthony","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"2026090301340066000_cit51","doi-asserted-by":"publisher","first-page":"eaau8959","DOI":"10.1126\/science.aau8959","article-title":"Opposing reactions in coenzyme A\nmetabolism sensitize Mycobacterium tuberculosis to\nenzyme inhibition","volume":"363","author":"Ballinger","year":"2019","journal-title":"Science"},{"key":"2026090301340066000_cit52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.aaw5224","article-title":"Expanding the anti-TB arsenal","volume":"363","author":"Mizrahi","year":"2019","journal-title":"Science"},{"key":"2026090301340066000_cit53","doi-asserted-by":"publisher","first-page":"a018564","DOI":"10.1101\/cshperspect.a018564","article-title":"Modeling tuberculosis in nonhuman primates","volume":"4","author":"Scanga","year":"2014","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"2026090301340066000_cit54","doi-asserted-by":"publisher","first-page":"20150363","DOI":"10.1098\/rsta.2015.0363","article-title":"Towards quantitative\nmass spectrometry-based metabolomics\nin microbial and mammalian systems","volume":"374","author":"Kapoore","year":"2016","journal-title":"Philos.\nTrans. R. Soc., A"},{"key":"2026090301340066000_cit55","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1513\/AnnalsATS.201505-279PS","article-title":"Metabolomics:\nApplications and Promise in Mycobacterial Disease","volume":"12","author":"Mirsaeidi","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"2026090301340066000_cit56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146658","article-title":"Real-Time\nInvestigation of Tuberculosis Transmission: Developing the Respiratory\nAerosol Sampling Chamber (RASC)","volume":"11","author":"Wood","year":"2016","journal-title":"PLoS One"},{"key":"2026090301340066000_cit57","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1021\/acsinfecdis.8b00369","article-title":"Single-Cell RNA\nSequencing to Understand Host\u2013Pathogen\nInteractions","volume":"5","author":"Penaranda","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"2026090301340066000_cit58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2018.02.004","article-title":"Metabolic\nheterogeneity in clonal microbial populations","volume":"45","author":"Takhaveev","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"2026090301340066000_cit59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1021\/acsinfecdis.7b00242","article-title":"The role of chemical biology in tuberculosis drug discovery\nand diagnosis","volume":"4","author":"Kolbe","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"2026090301340066000_cit63","doi-asserted-by":"crossref","unstructured":"Kamariza, M.; Shieh, P.; Ealand, C. S.; Peters, J. S.; Chu, B.; Rodriguez-Rivera, F. P.; Babu Sait, M. R.; Treuren, W. V.; Martinson, N.; Kalscheuer, R.; Kana, B. D.; Bertozzi, C. R.\n          Rapid Detection\nof Mycobacterium tuberculosis in Sputum\nwith a Solvatochromic Trehalose Probe.  Sci.\nTransl. Med.2018, 10, 10.1126\/scitranslmed.aam6310.","DOI":"10.1126\/scitranslmed.aam6310"},{"key":"2026090301340066000_cit60","doi-asserted-by":"publisher","first-page":"265ra166","DOI":"10.1126\/scitranslmed.3009501","article-title":"PET\/CT imaging correlates with treatment outcome in\npatients with multidrug-resistant tuberculosis","volume":"6","author":"Chen","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2026090301340066000_cit61","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/cbic.201800687","article-title":"Engineering the\nMycomembrane of Live Mycobacteria with an Expanded Set of Trehalose\nMonomycolate Analogues","volume":"20","author":"Fiolek","year":"2019","journal-title":"ChemBioChem"},{"key":"2026090301340066000_cit62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic Heterogeneity in Human\nLung Tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.9b00275","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/52\/8\/2340\/67144046\/acs.accounts.9b00275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/52\/8\/2340\/67144046\/acs.accounts.9b00275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:34:11Z","timestamp":1788413651000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/52\/8\/2340\/1264433\/Harnessing-Biological-Insight-to-Accelerate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":63,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,30]]},"published-print":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.9b00275","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}